Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6
Details for Australian Patent Application No. 2009301125 (hide)
International Classifications
Event Publications
21 April 2011 PCT application entered the National Phase
PCT publication WO2010/040756 Priority application(s): WO2010/040756
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009301131-New amide compounds as boosters of antivirals
2009301116-Deformable composite seal for bearing surfaces with a great lack of flatness
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser